Alignment Healthcare, Inc. Logo

Alignment Healthcare, Inc.

ALHC

(1.5)
Stock Price

13,67 USD

-22.59% ROA

-101.84% ROE

-14.64x PER

Market Cap.

2.242.036.000,00 USD

171.17% DER

0% Yield

-6.85% NPM

Alignment Healthcare, Inc. Stock Analysis

Alignment Healthcare, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Alignment Healthcare, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 DER

The stock maintains a fair debt to equity ratio (91%), indicating a reasonable balance between the money it owes and the ownership it possesses.

4 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

5 ROE

The stock's ROE indicates a negative return (-73.49%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-21.61%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 PBV

The stock's elevated P/BV ratio (6.5x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-143), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Alignment Healthcare, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Alignment Healthcare, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Alignment Healthcare, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Alignment Healthcare, Inc. Revenue
Year Revenue Growth
2019 756.961.000
2020 959.222.000 21.09%
2021 1.167.773.000 17.86%
2022 1.434.159.000 18.57%
2023 1.826.836.000 21.49%
2023 1.823.630.000 -0.18%
2024 2.725.144.000 33.08%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Alignment Healthcare, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 0
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Alignment Healthcare, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 109.932.000
2020 154.893.000 29.03%
2021 287.410.000 46.11%
2022 287.688.000 0.1%
2023 0 0%
2023 300.477.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Alignment Healthcare, Inc. EBITDA
Year EBITDA Growth
2019 -13.252.000
2020 9.466.000 240%
2021 -161.810.000 105.85%
2022 -111.329.000 -45.34%
2023 -96.200.000 -15.73%
2023 -105.296.000 8.64%
2024 -47.004.000 -124.01%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Alignment Healthcare, Inc. Gross Profit
Year Gross Profit Growth
2019 95.572.000
2020 166.230.000 42.51%
2021 128.732.000 -29.13%
2022 184.280.000 30.14%
2023 235.320.000 21.69%
2023 201.030.000 -17.06%
2024 303.896.000 33.85%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Alignment Healthcare, Inc. Net Profit
Year Net Profit Growth
2019 -59.278.000
2020 -39.125.000 -51.51%
2021 -212.958.000 81.63%
2022 -149.639.000 -42.31%
2023 -140.188.000 -6.74%
2023 -148.017.000 5.29%
2024 -96.040.000 -54.12%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Alignment Healthcare, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 0
2020 0 0%
2021 -1 100%
2022 -1 0%
2023 -1 0%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Alignment Healthcare, Inc. Free Cashflow
Year Free Cashflow Growth
2019 -1.037.000
2020 -8.147.000 87.27%
2021 -97.136.000 91.61%
2022 -69.201.000 -40.37%
2023 -3.561.000 -1843.3%
2023 -95.182.000 96.26%
2024 11.796.000 906.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Alignment Healthcare, Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 9.208.000
2020 7.561.000 -21.78%
2021 -78.776.000 109.6%
2022 -45.427.000 -73.41%
2023 5.992.000 858.13%
2023 -59.187.000 110.12%
2024 23.529.000 351.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Alignment Healthcare, Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 10.245.000
2020 15.708.000 34.78%
2021 18.360.000 14.44%
2022 23.774.000 22.77%
2023 9.553.000 -148.86%
2023 35.995.000 73.46%
2024 11.733.000 -206.78%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Alignment Healthcare, Inc. Equity
Year Equity Growth
2019 -78.711.000
2020 30.611.000 357.13%
2021 306.055.000 90%
2022 239.302.000 -27.89%
2023 158.071.000 -51.39%
2023 189.605.000 16.63%
2024 124.798.000 -51.93%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Alignment Healthcare, Inc. Assets
Year Assets Growth
2019 193.443.000
2020 338.502.000 42.85%
2021 630.895.000 46.35%
2022 633.863.000 0.47%
2023 591.880.000 -7.09%
2023 770.792.000 23.21%
2024 716.258.000 -7.61%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Alignment Healthcare, Inc. Liabilities
Year Liabilities Growth
2019 272.154.000
2020 307.891.000 11.61%
2021 324.840.000 5.22%
2022 394.561.000 17.67%
2023 433.809.000 9.05%
2023 581.187.000 25.36%
2024 591.460.000 1.74%

Alignment Healthcare, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
11.69
Net Income per Share
-0.8
Price to Earning Ratio
-14.64x
Price To Sales Ratio
1x
POCF Ratio
-13.63
PFCF Ratio
-10.82
Price to Book Ratio
18.09
EV to Sales
0.95
EV Over EBITDA
-19.85
EV to Operating CashFlow
-12.92
EV to FreeCashFlow
-10.24
Earnings Yield
-0.07
FreeCashFlow Yield
-0.09
Market Cap
2,24 Bil.
Enterprise Value
2,12 Bil.
Graham Number
3.42
Graham NetNet
-1.83

Income Statement Metrics

Net Income per Share
-0.8
Income Quality
1.07
ROE
-1.02
Return On Assets
-0.21
Return On Capital Employed
-0.38
Net Income per EBT
1
EBT Per Ebit
1.17
Ebit per Revenue
-0.06
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.11
Operating Profit Margin
-0.06
Pretax Profit Margin
-0.07
Net Profit Margin
-0.07

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.86
Free CashFlow per Share
-1.09
Capex to Operating CashFlow
-0.26
Capex to Revenue
0.02
Capex to Depreciation
1.79
Return on Invested Capital
-0.39
Return on Tangible Assets
-0.23
Days Sales Outstanding
29.96
Days Payables Outstanding
4.27
Days of Inventory on Hand
-95.58
Receivables Turnover
12.18
Payables Turnover
85.45
Inventory Turnover
-3.82
Capex per Share
0.23

Balance Sheet

Cash per Share
1,92
Book Value per Share
0,65
Tangible Book Value per Share
0.44
Shareholders Equity per Share
0.65
Interest Debt per Share
1.22
Debt to Equity
1.71
Debt to Assets
0.3
Net Debt to EBITDA
1.13
Current Ratio
1.61
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
338116000
Working Capital
0,23 Bil.
Intangibles to Total Assets
0.06
Average Receivables
0,17 Bil.
Average Payables
0,02 Bil.
Average Inventory
-463097500
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Alignment Healthcare, Inc. Dividends
Year Dividends Growth

Alignment Healthcare, Inc. Profile

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.

CEO
Mr. John E. Kao
Employee
1.536
Address
1100 West Town and Country Road
Orange, 92868

Alignment Healthcare, Inc. Executives & BODs

Alignment Healthcare, Inc. Executives & BODs
# Name Age
1 Ms. Dawn Christine Maroney
President of Health Markets & Chief Executive Officer of Health Plan
70
2 Mr. Hakan Kardes
Chief Experience Officer
70
3 Mr. Christopher J. Joyce
Chief Legal & Administrative Officer
70
4 Dr. Hyong J. Kim M.D.
Chief Medical Officer
70
5 Mr. Robert L. Scavo
Chief Information Officer
70
6 Dr. Donald S. Furman M.B.A., M.D.
Co-Founder & Chief Clinical Officer
70
7 Mr. John E. Kao
Founder, President, Chief Executive Officer & Director
70
8 Ms. Charlotte LeBlanc
Chief Accounting Officer and Senior Vice President
70
9 Mr. Robert Thomas Freeman
Chief Financial Officer
70
10 Mr. Andreas Wagner
Chief Human Resources Officer
70

Alignment Healthcare, Inc. Competitors